General
Preferred name
BIRABRESIB
Synonyms
OTX-015 ()
OTX015 (MK 8628/Birabresib) ()
MK-8628 ()
OTX 015 ()
OTX015 £¨MK 8628/Birabresib£© ()
OTX015 ()
MK 8628 ()
Birabresib (OTX015) ()
Y-803 anhydrous ()
OTX015 ANHYDROUS ()
OTX-015 ANHYDROUS ()
P&D ID
PD012534
CAS
202590-98-5
Tags
available
drug candidate
Drug indication
Solid tumour/cancer
Acute myeloid leukaemia
Glioblastoma multiforme
Myelodysplastic syndrome
Drug Status
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Birabresib (OTX-015) is a potent bromodomain (BRD2/3/4) inhibitor with IC50s ranging from 92 to 112 nM.
PRICE 86
DESCRIPTION OTX015 inhibits interaction between bromodomain and extra-terminal (BET) family of bromodomain-containing proteins (BRDs) BET domains and acetylated histone 4 (AcH4). It is an orally available novel BRD2/3/4 inhibitor with potent preclinical anti-tumour activity . OTX015 is an analogue of . (GtoPdb)
DESCRIPTION Birabresib (MK-8628) is a synthetic, small molecule inhibitor of the BET (Bromodomain and Extra-Terminal) family of bromodomain-containing proteins 2, 3 and 4 with potential antineoplastic activity. (TargetMol Bioactive Compound Library)
DESCRIPTION Potent and selective BRPF1 inhibitor (Tocris Bioactive Compound Library)
Cell lines
31
Organisms
0
Compound Sets
14
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
External IDs
26
Properties
(calculated by RDKit )
Molecular Weight
491.12
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
5
Aromatic Ring Count
4
cLogP
5.53
TPSA
92.4
Fraction CSP3
0.2
Chiral centers
1.0
Largest ring
7.0
QED
0.37
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
BRDs
Epigenetic Reader Domain
BRD2, BRD3, BRD4
BET-BRD inhibitor
Epigenetic Reader Domain,NSD
Primary Target
Bromodomains
MOA
Inhibitor
Bromodomain inhibitor
Pathway
Epigenetics
Chromatin/Epigenetic
Source data